SMMT ▲ +0.3% - Summit Therapeutics Inc.
$SMMT - Summit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
23-OCT-2026 04:40 PM ET
Share this post
More filings for $SMMT
SMMT ▼ -3.9% - Summit Therapeutics Inc.Oct 22, 2026SMMT ▲ +0.6% - Summit Therapeutics Inc.Oct 21, 2026SMMT ▲ +0.6% - Summit Therapeutics Inc.Oct 21, 2026SMMT ▲ +0.7% - Summit Therapeutics Inc.Oct 19, 2026SMMT ▲ +20.0% - Summit Therapeutics Inc.Sep 29, 2026SMMT ▲ +3.6% - Summit Therapeutics Inc.Sep 13, 2026
View full $SMMT filing history →💬 Comments
Loading comments…
Leave a comment